Mylan expands EpiPen recall to US

Meridian Medical Technologies, which manufacturers EpiPens for Mylan, on Friday expanded its global recall of the life-saving devices to include the U.S. market, reports Reuters.

Mylan on March 22 announced a recall of about 81,000 EpiPens distributed in Australia, New Zealand, Europe and Japan after two separate reports of the device failing to work properly during an emergency.

The recall now includes 13 lots of EpiPens distributed by Mylan between December 2015 and July 2016 to the U.S., along with additional markets in Asia, Europe and North and South America, according to the report.

The EpiPens may contain a defective part that prevents them from properly deploying, according to a Food and Drug Administration release.

More articles on supply chain:

Setting lower list prices — a first for pharma?
Swiss hospitals to transport lab samples via drone
4 latest FDA approvals


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months